CIK 0001160308
- Non-accelerated filer
- Smaller reporting company
Savara Inc
Sign in to watch- Ticker
- SVRA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 841318182
- Phone
- +51 285113796
- Business address
- 6836 BEE CAVE ROAD, BUILDING 3, SUITE 201, AUSTIN, TX, 78746
- Former names
- Mast Therapeutics, Inc., ADVENTRX PHARMACEUTICALS INC, BIOKEYS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 72 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2014-06-19 | Gorgas Gregory D. Senior VP, Commercial | Grant or award · Stock Option (Right to Buy) | +320,650 | 320,650 | ||
| 2014-06-19 | Roberts Brandi Chief Financial Officer & SVP | Grant or award · Stock Option (Right to Buy) | +336,600 | 336,600 | ||
| 2014-06-19 | RAMSAY DAVID A Director | Grant or award · Stock Option (Right to Buy) | +46,609 | 46,609 | ||
| 2014-06-19 | Culley Brian M CEO and Director | Grant or award · Stock Option (Right to Buy) | +1,114,250 | 1,114,250 | ||
| 2014-06-19 | EMANUELE ROBERT MARTIN Senior VP, Development | Grant or award · Stock Option (Right to Buy) | +285,400 | 285,400 | ||
| 2014-06-19 | Keran Patrick L President & COO | Grant or award · Stock Option (Right to Buy) | +1,114,250 | 1,114,250 | ||
| 2014-06-19 | LIEF JACK Director | Grant or award · Stock Option (Right to Buy) | +46,609 | 46,609 | ||
| 2014-06-19 | Vetticaden Santosh Chief Medical Officer & SVP | Grant or award · Stock Option (Right to Buy) | +529,300 | 529,300 | ||
| 2014-06-19 | DITTRICH HOWARD Director | Grant or award · Stock Option (Right to Buy) | +46,609 | 46,609 | ||
| 2014-06-19 | DITTRICH HOWARD Director | Grant or award · Stock Option (Right to Buy) | +46,609 | 46,609 | ||
| 2014-01-02 | Gorgas Gregory D. Senior VP, Commercial | Grant or award · Employee Stock Option (Right to Buy) | +49,500 | 49,500 | ||
| 2014-01-02 | Vetticaden Santosh Chief Medical Officer & SVP | Grant or award · Employee Stock Option (Right to Buy) | +295,100 | 295,100 | ||
| 2014-01-02 | EMANUELE ROBERT MARTIN Senior VP, Development | Grant or award · Employee Stock Option (Right to Buy) | +115,900 | 115,900 | ||
| 2014-01-02 | Keran Patrick L President & COO | Grant or award · Employee Stock Option (Right to Buy) | +650,300 | 650,300 | ||
| 2014-01-02 | Culley Brian M CEO and Director | Grant or award · Employee Stock Option (Right to Buy) | +650,300 | 650,300 | ||
| 2014-01-02 | Roberts Brandi Chief Financial Officer & SVP | Grant or award · Employee Stock Option (Right to Buy) | +101,200 | 101,200 | ||
| 2013-06-19 | LIEF JACK Director | Grant or award · Stock Option (Right to Buy) | +62,451 | 62,451 | ||
| 2013-06-19 | Shuster Lewis Director | Grant or award · Stock Option (Right to Buy) | +62,451 | 62,451 | ||
| 2013-06-19 | Roberts Brandi Chief Financial Officer & SVP | Grant or award · Employee Stock Option (Right to Buy) | +301,250 | 301,250 | ||
| 2013-06-19 | Keran Patrick L President & COO | Grant or award · Employee Stock Option (Right to Buy) | +907,300 | 907,300 |
Page 22 of 26 · 505 trades